• Heart disease test rolled out in UK
    Heart disease test rolled out in UK

Chromatography

Heart disease test rolled out in UK

May 28 2014

A new test that can analyse the patient's risk of developing a preventable form of heart disease will now be offered to people across the UK. The simple blood test uses DNA to identify whether or not the person has familial hypercholesterolaemia (FH).

The inherited condition, if left untreated, can significantly increase a patient's risk of experiencing a heart attack. Early intervention can bring the risk of people with FH to a normal level, but left undiagnosed nearly half of patients with the condition will develop heart disease before they are 60 years old.

Those diagnosed with FH are at a higher risk because they inherit a gene that causes high levels of "bad" cholesterol (LDL) in the blood. This can harden arteries and lead to an increased risk of heart disease, but now the new test can check whether the faulty gene is present or not.

A £1 million investment from the British Heart Foundation (BHF) will pay for a team of specialist nurses and will see the test extended to eight NHS trusts in England and Scotland, after a successful pilot scheme in Wales.  

The Welsh scheme, funded by the BHF and government, identified 1,183 people likely to have FH. It showed that 492 of these individuals carried the faulty gene, but their cholesterol levels were brought down to the normal range by statin treatment.

Although a number of trusts are included across England and Scotland, some areas will still not have access to nearby testing services, which has sparked criticism that NHS England should launch the service as a national initiative so that everyone has local testing available.

Steve Humphries, British Heart Foundation (BHF) professor of cardiovascular genetics at University College London, said he was "delighted" the test was now being rolled out in the UK.

He said: "With an estimated one-in-200 hundred families carrying an FH-causing faulty gene in the UK, the introduction of cascade testing represents a huge opportunity to identify and treat people before they suffer from potentially life-threatening heart problems."

As the gene is inherited, once a patient is diagnosed, the rest of their family will also be offered testing. When a patient has the FH gene, around half their siblings and children will also have it and be at the same risk of early heart disease.


Digital Edition

International Labmate Buyers' Guide 2024/25

June 2024

Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...

View all digital editions

Events

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

View all events